SHFHOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Scientist Home Future Health Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.70+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $40.32M
- P/E (TTM)
- –
- Dividend yield
- –
Scientist Home Future Health Ltd revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Retail Trading Business [Member] | $82.88K | $182.28K | $81.47K | $39.60K | $31.55K | $44.82K | – | – | 100.0% | +162.7% |
| Service Business [Member] | $1.43K | $6.48K | – | – | – | – | – | – | 1.7% | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Others (Delivery Fee) | $38.01K | $90.94K | $46.65K | $267 | $368 | $528 | – | – | 45.9% | +10229.6% |
| Scientist Home Cholipolysis Cholic Acid | $15.76K | $35.61K | – | – | – | – | – | – | 19.0% | – |
| Scientist Home High Concentration Proteinase | $7.64K | – | $10.78K | $12.35K | $8.73K | $11.90K | – | – | 9.2% | -12.4% |
| Scientist Home Mixed Gelatine Hydrolysate | $7.32K | $9.90K | $14.02K | $17.76K | $12.18K | $16.49K | – | – | 8.8% | -39.9% |
| Scientist Home Immune Study [Member] | $5.52K | $21.90K | – | – | – | – | – | – | 6.7% | – |
| Scientist Home Fibrosis Study [Member] | $4.94K | $12.11K | – | – | – | – | – | – | 6.0% | – |
| Scientist Home Chelation Study [Member] | $3.69K | $11.82K | – | – | – | – | – | – | 4.4% | – |
| Scientist Home Vein Cream | – | – | $3.50K | $3.34K | $5.99K | $9.81K | – | – | – | – |
| Scientist Home Spermaceti Cream | – | – | – | $1.67K | $795 | $2.47K | – | – | – | – |
| Scientist Home Bone Gelatine Hydrolysate | – | – | $2.87K | $2.47K | $2.55K | $1.53K | – | – | – | – |
| Scientist Home Calcification Cream | – | – | – | $1.76K | $948 | $2.10K | – | – | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-Hong Kong [Member] | $0 | $0 | $0 | $0 | $0 | $0 | – | – | 0.0% | – |
| Hong Kong | – | – | – | – | $31.55K | $44.82K | – | – | – | – |
From the segment and revenue-disaggregation notes of Scientist Home Future Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.